UBS Group »

G1 Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.7k 3.2k 3.05
2023-09-30 $306 213 1.44
2023-06-30 $6.8k 2.7k 2.49
2023-03-31 $17k 6.3k 2.68
2022-12-31 $43k 8.0k 5.43
2022-09-30 $789k 56k 14.08
2022-06-30 $999 213 4.69
2022-03-31 $1.6M 223k 7.38
2021-12-31 $2.5M 258k 9.84
2021-09-30 $1.7M 121k 14.08
2021-06-30 $324k 15k 21.22
2021-03-31 $1.6M 67k 24.06
2020-12-31 $4.0k 213 18.78
2020-09-30 $60k 5.2k 11.51
2020-06-30 $37k 1.6k 23.84
2020-03-31 $118k 11k 10.99
2019-12-31 $731k 27k 26.65
2019-09-30 $1.5M 67k 22.77
2019-06-30 $527k 17k 30.86
2019-03-31 $12k 713 16.83
2018-12-31 $1.8M 94k 19.64
2018-09-30 $403k 7.8k 51.89
2018-06-30 $95k 2.2k 43.34
2018-03-31 $39k 1.1k 35.29
2017-12-31 $27k 1.4k 19.61
2017-09-30 $9.4k 400 23.53
2017-06-30 $15k 895 17.19